GEMTUZUMAB OZOGAMICIN : A DETAILED ASSESSMENT

Gemtuzumab Ozogamicin Ozogamicin represents a novel advance in the approach of aggressive leukemic cancer, specifically acute myeloblastic cancer (AML). This novel conjugate links a humanized protein targeting against the CD33 antigen found on cancer blasts with calicheamicin gamma 1, resulting i